AnaptysBio

ANAB NASDAQ
54.50
-0.39
-0.71%
盘后: 54.50 0 0.00% 16:28 07/23 EDT
开盘
55.26
昨收
54.89
最高
55.68
最低
54.22
成交量
14.88万
成交均量(3M)
28.33万
52周最高
110.00
52周最低
51.73
换手率
0.55%
市值
14.73亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供AnaptysBio ANAB股票价格,AnaptysBio股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

AnaptysBio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. The Company develops its product candidates using its antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product pipeline includes ANB020 and ANB019, which are being developed to treat severe inflammatory disorders with unmet medical need. The Company's ANB020 product candidate is an antibody that inhibits the activity of interleukin-33, and is used for the treatment of severe adult asthma and severe adult peanut allergy. In addition, the Company is engaged in developing its ANB019 product candidate, an antibody that inhibits the interleukin-36 receptor, for the treatment of rare inflammatory diseases called generalized pustular psoriasis (GPP) and palmoplantar pustular psoriasis (PPP).
展开 >

最近浏览

名称
价格
涨跌幅